Related Experiment Video
Updated: Sep 29, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor
Taro Kijima1, Hideo Niwa, Richard A Steinman
1Departments of Otolaryngology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.
Abstract:
Epidermal growth factor receptor (EGFR) is up-regulated and contributes to the loss of growth control in squamous cell carcinoma of the head and neck (SCCHN). Previously, we reported an association between autocrine stimulation of EGFR and constitutive signal transducers and activators of transcription (STAT) 3 activation in SCCHN cells in vitro and in vivo. Here, we evaluated the role of activated STAT3 in tumor progression and EGFR-independent mitogenic signaling. We found that SCCHN cells stably transfected with a dominant active STAT3 construct expressed elevated levels of STAT3 target genes, including Bcl-X(L) and cyclin D1, and demonstrated increased proliferation in vitro and more rapid tumor growth rates in vivo. Cell cycle analysis demonstrated an increased proportion of STAT3 construct transfectants in G(2)-M. These findings provide evidence that constitutive STAT3 activation contributes to tumor growth in SCCHN, independent of the EGFR autocrine axis.
Insights
Constitutive activation of Signal Transducers and Activators of Transcription 3 (STAT3) drives tumor growth in head and neck squamous cell carcinoma (HNSCC). This STAT3 activation promotes cancer progression independently of Epidermal Growth Factor Receptor (EGFR) signaling.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Epidermal growth factor receptor (EGFR) is often upregulated in head and neck squamous cell carcinoma (HNSCC), contributing to uncontrolled cell growth.
- Previous research linked autocrine EGFR stimulation to constitutive Signal Transducers and Activators of Transcription 3 (STAT3) activation in HNSCC.
Purpose of the Study:
- To investigate the role of activated STAT3 in HNSCC tumor progression.
- To determine if STAT3 activation contributes to mitogenic signaling independently of EGFR.
Main Methods:
- Stable transfection of HNSCC cells with a dominant-active STAT3 construct.
- Analysis of STAT3 target gene expression (Bcl-X(L), cyclin D1).
- In vitro proliferation assays and in vivo tumor growth rate assessments.
- Cell cycle analysis.
Main Results:
- HNSCC cells with activated STAT3 showed increased expression of target genes like Bcl-X(L) and cyclin D1.
- These cells exhibited enhanced proliferation in vitro and accelerated tumor growth in vivo.
- Cell cycle analysis revealed a higher proportion of cells in the G(2)-M phase.
Conclusions:
- Constitutive STAT3 activation promotes tumor growth in HNSCC.
- STAT3 contributes to HNSCC progression independently of the EGFR autocrine pathway.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
TGF - β Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
